CBIC Implements 55th GST Council Recommendation: GST Exemption on Gene Therapy [Read Notification]

The Central Board of Indirect Taxes and Customs (CBIC) issued Notification No. 02/2025-Central Tax (Rate) announcing Goods and Service Tax (GST) Exemption on Gene Therapy. These amendments are based on recommendations from the 55th GST Council meeting, effective immediately.

1. Inclusion of Gene Therapy in Tax Exemption Schedule:

The Schedule of the principal notification now includes a new entry, S. No. 105A, 30, explicitly exempting gene therapy from GST. This change is expected to make these treatments more accessible and affordable for patients across the country.

S. No.	Chapter / Heading / Sub-heading / Tariff item	Description of Goods
105A	30	Gene Therapy

2. Revised Definition of Pre-Packaged and Labelled Goods

The notification also updates the definition of "pre-packaged and labelled" goods to include all retail commodities of up to 25 kilograms or 25 liters. This clarification references Section 2(l) of the Legal Metrology Act, 2009, ensuring compliance with specific labelling and declaration rules. The change targets enhanced transparency and regulatory adherence in the sale of pre-packed goods.

Complete Supreme Court Judgment on GST from 2017 to 2024 with Free E-Book Access, Click here

The amendments come into force with immediate effect

The amendments build on the principal notification No. 2/2017-Central Tax (Rate), originally published on June 28, 2017, and last amended on July 12, 2024. This move by the GST Council is part of an ongoing effort to simplify tax structures and promote equitable economic growth.

To Read the full text of the Notification CLICK HERE

Support our journalism by subscribing to Taxscan premium. Follow us on Telegram for quick updates